Drugs / BI 137882
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01348165 | May → Aug 2011 | — | Boehringer Ingelheim | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 137882 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01348165 ↗ |
| Route | Oral | “single rising oral doses” NCT01348165 ↗ |